Back to All Clinical Evidence
Detection of Bacterial Burden, Chronic Wounds
Novel Bacterial Auto-fluorescence Imaging Device Can Lead to more targeted debridement
Windy Cole, DPM; and Stacey Coe, BA, CCRP
Kent State University College of Podiatric Medicine, Independence, Ohio
Today’s Wound Clinic. April 2019.
References
Today’s Wound Clinic. April 2019.
Related Publications
Detection of Bacterial Burden
Detection of Bacterial Burden
MolecuLight Headquarters
425 University Avenue
Suite 700
Toronto, ON M5G 1T6
Canada
US Address
MolecuLight Corp.
2403 Sidney Street,
Suite 286
Pittsburgh, PA 15203
T. +1 647-362-4684
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com
Sitemap
©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.
Privacy Policy | Terms of Use | Software Privacy Policy
References
Today’s Wound Clinic. April 2019.